adplus-dvertising
Connect with us

Business

Canada Has Placed Its First Vaccine Order, but Don’t Expect a ‘Silver Bullet’ – The New York Times

Published

 on


For Canadians anxiously craving an inoculation against the coronavirus, this week brought both optimism and words of sobering caution.

Credit…Tony Luong for The New York Times

The federal government on Wednesday announced the first of many major deals to buy vaccines from two U.S.-based multinational drug companies: Pfizer and Moderna.

There will be “millions” of doses, Anita Anand, the cabinet minister responsible for the deal, said at a news conference. She did not offer any more details. But she and another cabinet minister said the government was negotiating deals with other vaccine makers, including some in Canada.

The catch in all of this is that neither Pfizer nor Moderna, nor anyone else, actually has a proven vaccine. The situation is similar to what happened with the Salk polio vaccine in the mid-1950s. As I wrote in last week’s newsletter, to speed up that vaccine, the federal government gambled and placed a bulk order to start production at Connaught Laboratories before trials on patients had proved that it was safe and effective.

Connaught, which played a crucial role in bringing the Salk vaccine to production, was the only game in Canada back then. This time around, many more companies are vying to make the coronavirus vaccine. The World Health Organization counts 28 possible vaccines now undergoing trials. Many more, including some Canadian candidates, are in earlier phases.

To guide its vaccine shopping, as well as its investments in Canadian vaccines and vaccine production, the federal government has turned to a panel of experts with backgrounds in science, medicine, public health and vaccine manufacturing.

#styln-briefing-block
font-family: nyt-franklin,helvetica,arial,sans-serif;
background-color: #ffffff;
color: #121212;
box-sizing: border-box;
margin: 30px auto;
max-width: 510px;
width: calc(100% – 40px);
border-top: 5px solid #121212;
border-bottom: 2px solid #121212;
padding: 5px 0 10px 0;

@media only screen and (min-width: 600px)
#styln-briefing-block
margin: 40px auto;

#styln-briefing-block a
color: #121212;

#styln-briefing-block ul
margin-left: 15px;

#styln-briefing-block a.briefing-block-link
color: #121212;
border-bottom: 1px solid #cccccc;
font-size: 0.9375rem;
line-height: 1.375rem;

#styln-briefing-block a.briefing-block-link:hover
border-bottom: none;

#styln-briefing-block .briefing-block-bullet::before
content: ‘•’;
margin-right: 7px;
color: #333;
font-size: 12px;
margin-left: -13px;
top: -2px;
position: relative;

#styln-briefing-block .briefing-block-bullet:not(:last-child)
margin-bottom: 0.75em;

#styln-briefing-block .briefing-block-header-section
margin-bottom: 16px;

#styln-briefing-block .briefing-block-header
font-weight: 700;
font-size: 1.125rem;
line-height: 1.375rem;
display: inline-block;
margin-bottom: 5px;

@media only screen and (min-width: 600px)
#styln-briefing-block .briefing-block-header
font-size: 1.25rem;
line-height: 1.5625rem;

#styln-briefing-block .briefing-block-header a
text-decoration: none;
color: #333;

#styln-briefing-block .briefing-block-header a::after
content: ‘›’;
position: relative;
font-weight: 500;
margin-left: 5px;

#styln-briefing-block .briefing-block-footer
font-size: 14px;
margin-top: 1.25em;
/* padding-top: 1.25em;
border-top: 1px solid #e2e2e2; */

#styln-briefing-block .briefing-block-briefinglinks a
font-weight: bold;
margin-right: 6px;

#styln-briefing-block .briefing-block-footer a
border-bottom: 1px solid #ccc;

#styln-briefing-block .briefing-block-footer a:hover
border-bottom: 1px solid transparent;

#styln-briefing-block .briefing-block-header
border-bottom: none;

#styln-briefing-block .briefing-block-lb-items
display: grid;
grid-template-columns: auto 1fr;
grid-column-gap: 20px;
grid-row-gap: 15px;
line-height: 1.2;

#styln-briefing-block .briefing-block-update-time a
color: #999;
font-size: 12px;

#styln-briefing-block .briefing-block-update-time.active a
color: #D0021B;

#styln-briefing-block .briefing-block-footer-meta
display: none;
justify-content: space-between;
align-items: center;

#styln-briefing-block .briefing-block-ts
color: #D0021B;
font-size: 12px;
display: block;

@media only screen and (min-width: 600px)
#styln-briefing-block a.briefing-block-link
font-size: 1.0625rem;
line-height: 1.5rem;

#styln-briefing-block .briefing-block-bullet::before
content: ‘•’;
margin-right: 10px;
color: #333;
font-size: 12px;
margin-left: -15px;
top: -2px;
position: relative;

#styln-briefing-block .briefing-block-update-time a
font-size: 13px;

@media only screen and (min-width: 1024px)
#styln-briefing-block
width: 100%;

As bets go, choosing Pfizer and Moderna is relatively conservative. Late last month, both companies began the first large-scale trials of their candidate vaccines in the United States.

[Read: Moderna and Pfizer Begin Late-Stage Vaccine Trials]

Assuming all goes well, Ms. Anand said, the first deliveries should appear next year.

But earlier in the week, Dr. Theresa Tam, Canada’s chief public health officer, warned against making too many assumptions about the power of vaccination to end the current pandemic.

At this stage, she said, vaccines are not “the silver bullet solution.”

She said many vaccines for other viruses only lessen the consequences of infection; they don’t prevent it.

As a result, she said, public health officials are working on the assumption that many of the measures now in place will be around for upward of two years.

Reggie Lo, a professor emeritus at the University of Guelph who focuses on vaccine development, told me this week that the first vaccine candidates, which may not be the most effective ones, may appear by the end of the year, but scaling up their production to inoculate billions will be a formidable challenge.

He also stressed that with the exception of smallpox, other deadly viruses have not been wiped out by decades of vaccination.

“The public needs to deal with this ‘forever,’” Dr. Lo said in an email. “Anyone who thinks the epidemic is over with development of a vaccine failed to grasp the enormity of the problem.”

Last week’s newsletter prompted the former Prime Minister Paul Martin to call me. His father, also Paul Martin, was, as federal health minister, the main player in Canada’s rollout and participation in development of the Salk vaccine.

Credit…Dave Chan for The New York Times

The younger Mr. Martin, who was infected with polio as a child, had a memory of that time that captures the uncertainty around vaccines.

.css-1wxds7fmargin-bottom:10px;font-family:nyt-franklin,helvetica,arial,sans-serif;font-weight:700;font-size:0.875rem;line-height:1.25rem;color:#333 !important;.css-2al2shfont-family:nyt-franklin,helvetica,arial,sans-serif;font-size:0.9375rem;line-height:1.25rem;color:#333;margin-bottom:0.78125rem;margin-top:20px;margin-bottom:5px;font-weight:700;@media (min-width:740px).css-2al2shfont-size:1.0625rem;line-height:1.5rem;margin-bottom:0.9375rem;@media (min-width:740px).css-2al2shmargin-bottom:10px;.css-1yyoic1font-family:nyt-franklin,helvetica,arial,sans-serif;font-size:0.9375rem;line-height:1.25rem;color:#333;margin-bottom:0.78125rem;@media (min-width:740px).css-1yyoic1font-size:1.0625rem;line-height:1.5rem;margin-bottom:0.9375rem;.css-zkk2wnmargin-bottom:20px;font-family:nyt-franklin,helvetica,arial,sans-serif;font-size:0.875rem;line-height:1.5625rem;color:#333;.css-1dvfdxomargin:10px auto 0px;font-family:nyt-franklin,helvetica,arial,sans-serif;font-weight:700;font-size:1.125rem;line-height:1.5625rem;color:#121212;@media (min-width:740px).css-1dvfdxofont-size:1.25rem;line-height:1.875rem;.css-16ed7iqwidth:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;-webkit-box-pack:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;padding:10px 0;background-color:white;.css-pmm6eddisplay:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;.css-pmm6ed > :not(:first-child)margin-left:5px;.css-5gimktfont-family:nyt-franklin,helvetica,arial,sans-serif;font-size:0.8125rem;font-weight:700;-webkit-letter-spacing:0.03em;-moz-letter-spacing:0.03em;-ms-letter-spacing:0.03em;letter-spacing:0.03em;text-transform:uppercase;color:#333;.css-5gimkt:aftercontent:’Collapse’;.css-rdoyk0-webkit-transition:all 0.5s ease;transition:all 0.5s ease;-webkit-transform:rotate(180deg);-ms-transform:rotate(180deg);transform:rotate(180deg);.css-eb027hmax-height:5000px;-webkit-transition:max-height 0.5s ease;transition:max-height 0.5s ease;.css-6mllg9-webkit-transition:all 0.5s ease;transition:all 0.5s ease;position:relative;opacity:0;.css-6mllg9:beforecontent:”;background-image:linear-gradient(180deg,transparent,#ffffff);background-image:-webkit-linear-gradient(270deg,rgba(255,255,255,0),#ffffff);height:80px;width:100%;position:absolute;bottom:0px;pointer-events:none;#masthead-bar-onedisplay:none;#masthead-bar-onedisplay:none;.css-19mumt8background-color:white;margin:30px 0;padding:0 20px;max-width:510px;@media (min-width:740px).css-19mumt8margin:40px auto;.css-19mumt8:focusoutline:1px solid #e2e2e2;.css-19mumt8 acolor:#326891;-webkit-text-decoration:none;text-decoration:none;border-bottom:2px solid #ccd9e3;.css-19mumt8 a:visitedcolor:#333;-webkit-text-decoration:none;text-decoration:none;border-bottom:2px solid #ddd;.css-19mumt8 a:hoverborder-bottom:none;.css-19mumt8[data-truncated] .css-rdoyk0-webkit-transform:rotate(0deg);-ms-transform:rotate(0deg);transform:rotate(0deg);.css-19mumt8[data-truncated] .css-eb027hmax-height:300px;overflow:hidden;-webkit-transition:none;transition:none;.css-19mumt8[data-truncated] .css-5gimkt:aftercontent:’See more’;.css-19mumt8[data-truncated] .css-6mllg9opacity:1;.css-a8d9ozborder-top:5px solid #121212;border-bottom:2px solid #121212;margin:0 auto;padding:5px 0 0;overflow:hidden;

His father, he said, was usually good spirited at home. But one afternoon in 1955 when Mr. Martin went into his library, his father was unusually distracted and testy. He was told to leave and go see his mother.

From her, Mr. Martin learned that his father was grappling with perhaps the most difficult decision of his life: whether to continue with plans to vaccinate Canada. A batch of vaccines made by Cutter Laboratories, an American company, had been determined to be defective and ended up infecting 40,000 children. About 200 of them were left paralyzed, and 10 died.

As a result, the United States suspended polio vaccination for several months, a decision that led to infections, deaths and paralysis. Ultimately, the elder Mr. Martin was convinced that Connaught’s vaccine was safe, and Canada continued its inoculations without incident.

The stakes, if anything, are greater now as the world rushes to produce a coronavirus vaccine. We all may be called to have patience and realistic expectations.

Credit…Aaron Vincent Elkaim for The New York Times
  • Even before it opened, the Canadian Museum for Human Rights in Winnipeg had prompted heated debate. Now a stinging review has concluded that racism is systemic and widespread within its walls.

  • President Trump reinstated tariffs on aluminum from Canada, just a month after the new trade deal between Canada, the United States and Mexico came into effect.

  • In skeleton, the headfirst Olympic sledding sport, the opportunity for unlimited training on the track can be a huge advantage. But Canadian Olympians who had such access believe it was bad for their brains, Matthew Futterman reports.

  • A former top Saudi intelligence official filed a lawsuit in Washington claiming that Crown Prince Mohammed bin Salman sent a team of agents to Canada to kill him shortly after another team of Saudi operatives killed and dismembered Jamal Khashoggi, the dissident Saudi writer.

  • Setsuko Thurlow, a survivor of the atomic bombing in Hiroshima 75 years ago and a resident of Toronto, is using her personal story to push countries, including Canada, to ratify the Treaty on the Prohibition of Nuclear Weapons, which was formally adopted at the United Nations three years ago.

  • Toronto’s Scotiabank Arena is empty inside and out, as the N.H.L. playoffs take place there (and in Edmonton) without fans, under a system that requires even the hometown Leafs to stay in hotels.

  • Karen Schwartz, a dual U.S.-Canada citizen, traveled from Colorado to visit her father in Calgary. She found that a lot of Canadians are keeping tabs on American visitors.


A native of Windsor, Ontario, Ian Austen was educated in Toronto, lives in Ottawa and has reported about Canada for The New York Times for the past 16 years. Follow him on Twitter at @ianrausten.


We’re eager to have your thoughts about this newsletter and events in Canada in general. Please send them to nytcanada@nytimes.com.

Forward it to your friends, and let them know they can sign up here.

Let’s block ads! (Why?)

728x90x4

Source link

Business

Japan’s SoftBank returns to profit after gains at Vision Fund and other investments

Published

 on

 

TOKYO (AP) — Japanese technology group SoftBank swung back to profitability in the July-September quarter, boosted by positive results in its Vision Fund investments.

Tokyo-based SoftBank Group Corp. reported Tuesday a fiscal second quarter profit of nearly 1.18 trillion yen ($7.7 billion), compared with a 931 billion yen loss in the year-earlier period.

Quarterly sales edged up about 6% to nearly 1.77 trillion yen ($11.5 billion).

SoftBank credited income from royalties and licensing related to its holdings in Arm, a computer chip-designing company, whose business spans smartphones, data centers, networking equipment, automotive, consumer electronic devices, and AI applications.

The results were also helped by the absence of losses related to SoftBank’s investment in office-space sharing venture WeWork, which hit the previous fiscal year.

WeWork, which filed for Chapter 11 bankruptcy protection in 2023, emerged from Chapter 11 in June.

SoftBank has benefitted in recent months from rising share prices in some investment, such as U.S.-based e-commerce company Coupang, Chinese mobility provider DiDi Global and Bytedance, the Chinese developer of TikTok.

SoftBank’s financial results tend to swing wildly, partly because of its sprawling investment portfolio that includes search engine Yahoo, Chinese retailer Alibaba, and artificial intelligence company Nvidia.

SoftBank makes investments in a variety of companies that it groups together in a series of Vision Funds.

The company’s founder, Masayoshi Son, is a pioneer in technology investment in Japan. SoftBank Group does not give earnings forecasts.

___

Yuri Kageyama is on X:

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Trump campaign promises unlikely to harm entrepreneurship: Shopify CFO

Published

 on

 

Shopify Inc. executives brushed off concerns that incoming U.S. President Donald Trump will be a major detriment to many of the company’s merchants.

“There’s nothing in what we’ve heard from Trump, nor would there have been anything from (Democratic candidate) Kamala (Harris), which we think impacts the overall state of new business formation and entrepreneurship,” Shopify’s chief financial officer Jeff Hoffmeister told analysts on a call Tuesday.

“We still feel really good about all the merchants out there, all the entrepreneurs that want to start new businesses and that’s obviously not going to change with the administration.”

Hoffmeister’s comments come a week after Trump, a Republican businessman, trounced Harris in an election that will soon return him to the Oval Office.

On the campaign trail, he threatened to impose tariffs of 60 per cent on imports from China and roughly 10 per cent to 20 per cent on goods from all other countries.

If the president-elect makes good on the promise, many worry the cost of operating will soar for companies, including customers of Shopify, which sells e-commerce software to small businesses but also brands as big as Kylie Cosmetics and Victoria’s Secret.

These merchants may feel they have no choice but to pass on the increases to customers, perhaps sparking more inflation.

If Trump’s tariffs do come to fruition, Shopify’s president Harley Finkelstein pointed out China is “not a huge area” for Shopify.

However, “we can’t anticipate what every presidential administration is going to do,” he cautioned.

He likened the uncertainty facing the business community to the COVID-19 pandemic where Shopify had to help companies migrate online.

“Our job is no matter what comes the way of our merchants, we provide them with tools and service and support for them to navigate it really well,” he said.

Finkelstein was questioned about the forthcoming U.S. leadership change on a call meant to delve into Shopify’s latest earnings, which sent shares soaring 27 per cent to $158.63 shortly after Tuesday’s market open.

The Ottawa-based company, which keeps its books in U.S. dollars, reported US$828 million in net income for its third quarter, up from US$718 million in the same quarter last year, as its revenue rose 26 per cent.

Revenue for the period ended Sept. 30 totalled US$2.16 billion, up from US$1.71 billion a year earlier.

Subscription solutions revenue reached US$610 million, up from US$486 million in the same quarter last year.

Merchant solutions revenue amounted to US$1.55 billion, up from US$1.23 billion.

Shopify’s net income excluding the impact of equity investments totalled US$344 million for the quarter, up from US$173 million in the same quarter last year.

Daniel Chan, a TD Cowen analyst, said the results show Shopify has a leadership position in the e-commerce world and “a continued ability to gain market share.”

In its outlook for its fourth quarter of 2024, the company said it expects revenue to grow at a mid-to-high-twenties percentage rate on a year-over-year basis.

“Q4 guidance suggests Shopify will finish the year strong, with better-than-expected revenue growth and operating margin,” Chan pointed out in a note to investors.

This report by The Canadian Press was first published Nov. 12, 2024.

Companies in this story: (TSX:SHOP)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

RioCan cuts nearly 10 per cent staff in efficiency push as condo market slows

Published

 on

 

TORONTO – RioCan Real Estate Investment Trust says it has cut almost 10 per cent of its staff as it deals with a slowdown in the condo market and overall pushes for greater efficiency.

The company says the cuts, which amount to around 60 employees based on its last annual filing, will mean about $9 million in restructuring charges and should translate to about $8 million in annualized cash savings.

The job cuts come as RioCan and others scale back condo development plans as the market softens, but chief executive Jonathan Gitlin says the reductions were from a companywide efficiency effort.

RioCan says it doesn’t plan to start any new construction of mixed-use properties this year and well into 2025 as it adjusts to the shifting market demand.

The company reported a net income of $96.9 million in the third quarter, up from a loss of $73.5 million last year, as it saw a $159 million boost from a favourable change in the fair value of investment properties.

RioCan reported what it says is a record-breaking 97.8 per cent occupancy rate in the quarter including retail committed occupancy of 98.6 per cent.

This report by The Canadian Press was first published Nov. 12, 2024.

Companies in this story: (TSX:REI.UN)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending